
Benzinga Pro data, Viveve Medical (NASDAQ:VIVE) reported Q4 sales of $1.71 million. Earnings fell to a loss of $6.33 million, resulting in a 8.02% decrease from last quarter. Viveve Medical collected $1.62 million in revenue during Q3, but reported earnings showed a $5.86 million loss.